RECQL and neoplasm: Evidence that RecQ helicases function to preserve genomic stability at stalled or broken replication forks [2] prompted us to examine the sensitivity of RECQ1-depleted cells to CPT, an anti-tumor drug that inhibits the topoisomerase-induced DNA breakage-reunion reaction [35].